All Type of News
NHIC to prompt reimbursement for medical institutions in disaster zones.
The National Health Insurance Corporation (NHIC: President Lee Seong-jae) will speed up the NHI reimbursement for the medical institutions and pharmacies in the 9 typhoon victimized cities including Busan and Daegu fr...
KPMA vows to foster fair trade competition
The Korea Pharmaceutical Manufacturers Association said it would closely monitor all promotional assistance programs of pharmaceutical firms associated with the oncoming symposia at home and abroad, as part of its eff...
Drug-related transaction to be reformed
The Ministry of Health and Welfare had its first drug distribution planning committee's meeting on September 18, saying that to ensure transparency in drug-related transaction, the active operation of a drug distribut...
Government budget on R&D new drug projects expected to grow slightly next year
The Korea Drug Research Association said that the government funding designed to promote the domestic pharmaceutical industry's R&D new drug projects is expected to grow slightly next year, as a result of its vigorous...
IMS denying any representing business for Zuellig.
IMS Health made it clear over the Yakup press headline news titled "An upheaval sign in drug distribution communities over Zuellig issues" dated on Sept. 15 that IMS transmitted informations directly to Zuellig upon w...
Total 725 drugs subjected to Bio-equivalent tests.
Upon receipt of the official announcement from the KFDA, the Health Insurance Review Agency (HIRA) declared that 41 drugs were additionally included to the items proven of bio-equivalent test, which increased currentl...
Korean scientists developed new test for early lung cancer.
A lung cancer gene can be detected by Korean scientists, Dr. Chun Chang-ho of Daegu Catholic Medical Center, Dr. Park Jong-wook of Dongsan Medical Center and Prof. Cheon Sang-hoon of Seoul National Univ. medical schoo...
Additional designation of dextromethrophan into psychotropic substance raising concerns
Following the government's move to designate dextromethrophan as one of psychotropic substances from this October, a number of domestic pharmaceutical firms are now bracing for measures to boost their sales of cold re...
Hanmi Pharm's cefixime won COS
Hanmi Pharm said that it has acquired from the European Pharmacopoeia Commission the certification of suitability (COS) on cefixime, antibiotic bulk material, for the third time following ceftriaxone and cefotaxime, a...
Pharmacies promote anti-obesity campaign in autumn for better management
Pharmaceutical business sources say that the selling of diet items this autumn seems likely to be brisk thanks to unabated diet fever for the past several years, and pharmacists' active anti-obesity campaign will make...
